The relationship between slowing EEGs and the progression of parkinson's disease

Journal of Clinical Neurophysiology

Volumn 26, Issue 6, 2009, Pages 426-429

  Morita, Akihiko ^a   Kamei, Satoshi ^a   Serizawa, Kan ^a   Mizutani, Tomohiko ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Electrode distribution; Hoehn Yahr stage; Parkinson's disease; Quantitative EEG

Indexed keywords

ADULT; AGED; ARTICLE; DEGENERATIVE DISEASE; DISEASE COURSE; DISEASE DURATION; ELECTRODE; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; IMAGING SYSTEM; INSTRUMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; MINI MENTAL STATE EXAMINATION; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; QUANTITATIVE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; BRAIN MAPPING; DISEASE PROGRESSION; ELECTRODES; ELECTROENCEPHALOGRAPHY; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPECTRUM ANALYSIS; STATISTICS AS TOPIC;

EID: 74249090957     PISSN: 07360258     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNP.0b013e3181c2bce6     Document Type: Article

References (25)

1. Braak H, Ghebremedhin E, Rub U, et al. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 2004;318:121-134.
2. Burn DJ, Rowan EN, Allan LM, et al. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2006;77:585-589.
3. Caviness JN, Hentz JG, Evidente VG, et al. Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's disease. Parkinsonism Relat Disord. 2007;13:348-354.
4. Fahn S, Elton R, Members of the UPDRS Development Committee. Unified Parkinson's Disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Developments in Parkinson's Disease, Vol.2. Florham Park, NJ: Macmillan Health Care Information; 1987:293-304.
5. Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol. 1987;149: 351-356.
6. Geser F, Wenning GK, Poewe W, McKeith I. How to diagnose dementia with Lewy bodies: state of the art. Mov Disord. 2005;20(Suppl 12):S11-S20.
7. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988;51: 745-752.
8. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427-442.
9. Kamei S, Hara M, Serizawa K, et al. Executive dysfunction using behavioral assessment of the dysexecutive syndrome in Parkinson's disease. Mov Disord. 2008;23:566-573.
10. Kamei S, Oga K, Matsuura M, et al. Correlation between quantitative-EEG alterations and age in patients with interferon-alpha-treated hepatitis C. J Clin Neurophysiol. 2005;22:49-52.
11. Kamei S, Sakai T, Matsuura M, et al. Alterations of quantitative EEG and mini-mental state examination in interferon-alpha-treated hepatitis C. Eur Neurol. 2002;48:102-107.
12. Kamei S, Tanaka N, Mastuura M, et al. Blinded, prospective, and serial evaluation by quantitative-EEG in interferon-alpha-treated hepatitis-C. Acta Neurol Scand. 1999;100:25-33.
13. Lindau M, Jelic V, Johansson SE, et al. Quantitative EEG abnormalities and cognitive dysfunctions in frontotemporal dementia and Alzheimer's disease. Dement Geriatr Cogn Disord. 2003;15:106-114.
14. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113-1124.
15. Neufeld MY, Blumen S, Aitkin I, et al. EEG frequency analysis in demented and nondemented parkinsonian patients. Dementia. 1994;5:23-28.
16. Neufeld MY, Inzelberg R, Korczyn AD. EEG in demented and non-demented parkinsonian patients. Acta Neurol Scand. 1988;78:1-5.
17. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303-308.
18. Pezard L, Jech R, Ruzicka E. Investigation of non-linear properties of multichannel EEG in the early stages of Parkinson's disease. Clin Neurophysiol. 2001;112:38-45.
19. Primavera A, Novello P. Quantitative electroencephalography in Parkinson's disease, dementia, depression and normal aging. Neuropsychobiology. 1992; 25:102-105.
20. Riedel O, Klotsche J, Spottke A, et al. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD). J Neurol. 2008;255: 255-264.
21. Serizawa K, Kamei S, Morita A, et al. Comparison of quantitative EEGs between Parkinson disease and age-adjusted normal controls. J Clin Neurophysiol. 2008;25:361-366.
22. Soikkeli R, Partanen J, Soininen H, et al. Slowing of EEG in Parkinson's disease. Electroencephalogr Clin Neurophysiol. 1991;79:159-165.
23. Tanaka H, Koenig T, Pascual-Marqui RD, et al. Event-related potential and EEG measures in Parkinson's disease without and with dementia. Dement Geriatr Cogn Disord. 2000;11:39-45.
24. Yeager CL, Alberts WW, Denature LD. Effect of stereotaxic surgery upon electroencephalographic status of parkinsonian patients. Neurology. 1966; 16:904-910.
25. Zijlmans JC, Pasman JW, Horstink MW, et al. EEG findings in patients with vascular parkinsonism. Acta Neurol Scand. 1998;98:243-247.